OGEN
Oragenics Inc
$0.59
+0.02 (+3.51%)
At close · Jul 8
Market Cap
$2.67M
Shares
4,511,957
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.59
Open$0.58
Day$0.57–0.59
52W$0.50–1.54
Avg vol 30d49K
Short int753K · 16.7% float · 13.0d
Short vol28%
DataJan 2020–Jul 2026
Filing10-Q · May 8
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−30%
below
Price vs 50-day avg
−1%
below
RSI (14)
49
neutral
MACD trend
Negative
52-week position
9%
near low
Momentum
relative strength
1-month return
−2%
trailing
6-month return
−33%
trailing
YTD return
−24%
this year
Relative strength
−41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+17% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
16.68% of float · ▲ +6.2% MoM · 13.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
21 holders — near 1-yr high, broad support
Squeeze score
71
high risk · 0–100
Fundamentals
Revenue growth
−9%
Y/Y
Gross margin
0%
EPS growth
+90%
Y/Y
Free cash flow
$-9.4M
Balance sheet
$4.4M
net cash
Quant / Vol
risk profile
Volatility
72%
annualized · 1-yr
Max drawdown
−67%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−30%
Bearish
Price vs 50-day avg
−1%
Neutral
RSI (14)
49
Neutral
MACD trend
Negative
Bearish
52-week position
9%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+17% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
16.68% of float · ▲ +6.2% MoM · 13.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
21 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $1 · 9%
52-wk high $2
vs 200-day avg -30%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OGEN
this stock
Oragenics Inc
|
$2.67M | -24.4% | -8.9% | — | 16.7% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OGEN | +1.7% | -1.7% | -33.0% | +1.7% | -24.4% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +0.8% | -3.1% | -40.5% | +1.6% | -34.0% |